IL17A and cancer: The authors clearly indicated that the levels of Th17 cells and IL-17A mRNA were increased in NSCLC patients (both in blood and cancerous lung tissue), and in vitro studies revealed that IL-17A could promote the invasion, migration, and cancer stem cell-like properties of NSCLC cells [109].